Background Immune checkpoint inhibitors (ICIs) are being investigated for their role as an
adjunct in the multimodal treatment of esophageal adenocarcinoma (EAC). The most …

Background: The knowledge of both patterns and risk of relapse following resection for
esophageal cancer is crucial for establishing appropriate surveillance schedules. The aim of …

Background Neoadjuvant chemoradiotherapy (NCRT) plus surgery is the standard treatment
for esophageal squamous cell carcinoma (ESCC); however, further analysis is needed to …

Objective: Determine whether adjuvant chemotherapy is associated with a survival benefit in
high risk T2-4a, pathologically node-negative distal esophageal adenocarcinoma. Summary …

Esophago-gastric malignancies are associated with a high recurrence rate; yet there is a
lack of evidence to inform guidelines for the standardization and structure of postoperative …

Introduction Neoadjuvant chemoradiation therapy (NCRT) for cT1b esophageal cancer is
not recommended despite the risk of pathologic upstaging with increased depth of …

Background Endoscopic mucosal resection (EMR) has emerged as an esophageal-
preserving treatment for T1 esophageal adenocarcinoma (EAC); however, only patients with …

Objective As endoscopic approaches become more widely used to treat early-stage
esophageal cancer, reliably identifying patients with less-aggressive tumors is paramount …

Background: We analyzed local regional recurrence patterns of thoracic esophageal
carcinoma after three-field lymph node dissection (3-FLD) with and without postoperative …

目的: 通过TCGA 和GEO 数据库筛选与食管腺癌相关的关键基因, 并分析其生物学功能,
相关信号通路和临床意义. 方法: 综合TCGA 数据库食管腺癌数据和GEO 数据库GSE92396 …